CTXT PTY LTD has a total of 72 patent applications. It decreased the IP activity by 68.0%. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), United Kingdom and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are RAZE THERAPEUTICS INC, MOREPEN LAB LTD and BIOIMICS AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 16 | |
#2 | United Kingdom | 15 | |
#3 | EPO (European Patent Office) | 13 | |
#4 | United States | 11 | |
#5 | Canada | 4 | |
#6 | Australia | 3 | |
#7 | Taiwan | 2 | |
#8 | Argentina | 1 | |
#9 | Brazil | 1 | |
#10 | Colombia | 1 | |
#11 | Israel | 1 | |
#12 | Republic of Korea | 1 | |
#13 | Peru | 1 | |
#14 | Singapore | 1 | |
#15 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Stupple Paul Anthony | 45 |
#2 | Camerino Michelle Ang | 37 |
#3 | Walker Scott Raymond | 36 |
#4 | Foitzik Richard Charles | 25 |
#5 | Morrow Benjamin Joseph | 22 |
#6 | Bozikis Ylva Elisabet Bergman | 16 |
#7 | Lagiakos Helen Rachel | 15 |
#8 | Bergman Ylva Elisabet | 12 |
#9 | Lagiakos H Rachel | 10 |
#10 | Hemley Catherine Fae | 9 |
Publication | Filing date | Title |
---|---|---|
GB202009944D0 | Compounds | |
GB201918761D0 | Compounds | |
GB201916847D0 | Compounds | |
GB201910304D0 | Compounds | |
GB201910305D0 | Compounds | |
GB201810581D0 | Compounds | |
GB201810092D0 | Compounds | |
GB201807924D0 | Compounds | |
GB201713962D0 | Compounds | |
GB201604027D0 | Compounds | |
GB201604029D0 | Compounds | |
GB201604031D0 | Compounds | |
GB201604030D0 | Compounds | |
GB201604022D0 | Compounds | |
GB201604020D0 | Compounds | |
WO2016070241A1 | Triazine compounds, compositions and synthesis | |
WO2016034671A1 | Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived prmt5-inhibitors | |
EP3189041A1 | Tetrahydroisoquinoline derived prmt5-inhibitors |